Home/Filings/4/A/0001209191-18-059725
4/A//SEC Filing

Walsh Des 4/A

Accession 0001209191-18-059725

CIK 0001180262other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 4:30 PM ET

Size

12.1 KB

Accession

0001209191-18-059725

Insider Transaction Report

Form 4/AAmended
Period: 2018-11-12
Walsh Des
EVP/Worldwide Ops. & Sales
Transactions
  • Exercise/Conversion

    Stock Appreciation Rights

    2018-11-12300,0000 total
    Exercise: $3.41From: 2014-02-27Exp: 2019-02-27Common Stock (300,000 underlying)
  • Exercise/Conversion

    Common Stock

    2018-11-12$3.41/sh+300,000$1,023,000618,178 total
  • Disposition to Issuer

    Common Stock

    2018-11-12$54.33/sh18,830$1,023,034599,348 total
  • Tax Payment

    Common Stock

    2018-11-12$54.33/sh148,037$8,042,850451,311 total
Footnotes (4)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The reporting person received 133,133 shares of common stock upon the net exercise of 300,000 stock appreciation rights ("SARS"). The reporting person forfeited 18,830 shares of common stock underlying the SARS in payment of the exercise price and 148,037 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on November 12, 2018 of $54.33. The reporting person did not sell any shares received from this net exercise of SARS.
  • [F3]On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 159,089 additional shares of common stock.
  • [F4]These SARS were previously reported as covering 150,000 shares at an exercise price of $6.82 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.

Issuer

HERBALIFE NUTRITION LTD.

CIK 0001180262

Entity typeother

Related Parties

1
  • filerCIK 0001373040

Filing Metadata

Form type
4/A
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:30 PM ET
Size
12.1 KB